{'52WeekChange': -0.7616334,
 'SandP52WeekChange': 0.0644362,
 'address1': '500 Boylston Street',
 'address2': '13th floor',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.55,
 'askSize': 1400,
 'averageDailyVolume10Day': 1311100,
 'averageVolume': 1627485,
 'averageVolume10days': 1311100,
 'beta': 2.594223,
 'beta3Year': None,
 'bid': 2.51,
 'bidSize': 1000,
 'bookValue': 2.075,
 'category': None,
 'circulatingSupply': None,
 'city': 'Boston',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.54,
 'dayLow': 2.37,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.188,
 'enterpriseToRevenue': None,
 'enterpriseValue': 15135835,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 2.3085713,
 'fiftyTwoWeekHigh': 11.36,
 'fiftyTwoWeekLow': 0.86,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 25815254,
 'forwardEps': -0.67,
 'forwardPE': -3.7462685,
 'fromCurrency': None,
 'fullTimeEmployees': 12,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.15949,
 'heldPercentInstitutions': 0.39508,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/restorbio.com',
 'longBusinessSummary': 'resTORbio, Inc., a clinical-stage biopharmaceutical '
                        'company, develops medicine to treat aging-related '
                        'diseases. Its lead program is selectively inhibits '
                        'the target of rapamycin complex 1 (TORC1), an '
                        'evolutionary conserved pathway that contributes to '
                        'the age-related decline in function of various organ '
                        'systems, including immune, neurologic, and cardiac '
                        "functions. The company's lead drug candidate is "
                        'RTB101, an oral, selective, and potent inhibitor of '
                        'TORC1 that is in Phase 1b/2a clinical trial for the '
                        "treatment of Parkinson's disease, as well as to treat "
                        'neurodegenerative diseases. resTORbio, Inc. was '
                        'founded in 2016 and is headquartered in Boston, '
                        'Massachusetts.',
 'longName': 'resTORbio, Inc.',
 'market': 'us_market',
 'marketCap': 91481720,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_427650761',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -78708000,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.45,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.09,
 'phone': '857 315 5528',
 'previousClose': 2.46,
 'priceHint': 4,
 'priceToBook': 1.2096385,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.54,
 'regularMarketDayLow': 2.37,
 'regularMarketOpen': 2.45,
 'regularMarketPreviousClose': 2.46,
 'regularMarketPrice': 2.45,
 'regularMarketVolume': 436192,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 36446900,
 'sharesPercentSharesOut': 0.0154,
 'sharesShort': 560879,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 693015,
 'shortName': 'resTORbio, Inc.',
 'shortPercentOfFloat': 0.0201,
 'shortRatio': 0.57,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'TORC',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.176,
 'twoHundredDayAverage': 1.6544244,
 'volume': 436192,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.restorbio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02116'}